CD274 and non-small cell lung carcinoma: To test this hypothesis, we evaluated the association of polymorphisms in PD-1, PD-L1, and CTLA-4 genes with the chemotherapy response and survival of NSCLC patients undergoing 1st line paclitaxel-cisplatin chemotherapy.